THERESA MALCOM: Open Payments
NPI 1871224576 · ELKHART, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$662 in 27 payments from 12 companies in 2025. Trend: 2023 $367 · 2024 $858 · 2025 $662
Food & beverage: $645Education: $17
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 10 | $198 |
| Ethicon Inc. | 2 | $163 |
| Viatris Specialty LLC | 2 | $51 |
| Genentech USA, Inc. | 2 | $41 |
| Insmed, Inc. | 2 | $40 |
| AstraZeneca Pharmaceuticals LP | 2 | $35 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $34 |
| Regeneron Healthcare Solutions, Inc. | 1 | $27 |
| Amgen Inc. | 1 | $22 |
| Grifols USA, LLC | 1 | $18 |
Products named: NUCALA, Monarch Platform, YUPELRI, Xolair, GLASSIA, TRELEGY ELLIPTA, DUPIXENT, Arikayce.
Industry payments across IN — which companies pay providers there.
